ProPhase Labs Inc. (PRPH)
0.30
-0.01 (-2.76%)
At close: Apr 14, 2025, 3:59 PM
-2.76% (1D)
| Bid | 0.3 |
| Market Cap | 12.75M |
| Revenue (ttm) | 6.77M |
| Net Income (ttm) | -53.36M |
| EPS (ttm) | -2.42 |
| PE Ratio (ttm) | -0.13 |
| Forward PE | -0.59 |
| Analyst | n/a |
| Ask | 0.35 |
| Volume | 1,085,127 |
| Avg. Volume (20D) | 10,382,314 |
| Open | 0.31 |
| Previous Close | 0.31 |
| Day's Range | 0.30 - 0.33 |
| 52-Week Range | 0.22 - 7.48 |
| Beta | -0.55 |
About PRPH
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also prov...
Sector Healthcare
IPO Date Apr 4, 1994
Employees 96
Stock Exchange NASDAQ
Ticker Symbol PRPH
Website https://www.prophaselabs.com
Next Earnings Release
ProPhase Labs Inc. is scheduled to release its earnings on May 8, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
-8.11%
ProPhase Labs shares are trading lower after the c...
Unlock content with
Pro Subscription
1 month ago
+3.51%
ProPhase Labs shares are trading higher after the company announced it has been partnering with Crown Medical Collections.
